These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12112531)

  • 1. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
    Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
    Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
    Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
    Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.
    Rickert CH; Riemenschneider MJ; Schachenmayr W; Richter HP; Bockhorn J; Reifenberger G; Paulus W
    Brain Pathol; 2009 Jul; 19(3):431-8. PubMed ID: 18691268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas.
    Saigusa K; Hashimoto N; Tsuda H; Yokoi S; Maruno M; Yoshimine T; Aoyagi M; Ohno K; Imoto I; Inazawa J
    Cancer Sci; 2005 Oct; 96(10):676-83. PubMed ID: 16232199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis.
    Lowder L; Hauenstein J; Woods A; Chen HR; Rupji M; Kowalski J; Olson JJ; Saxe D; Schniederjan M; Neill S; Weinberg B; Sengupta S
    J Neurooncol; 2019 Jul; 143(3):381-392. PubMed ID: 31073965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma.
    Li A; Hancock JC; Quezado M; Ahn S; Briceno N; Celiku O; Ranjan S; Aboud O; Colwell N; Kim SA; Nduom E; Kuhn S; Park DM; Vera E; Aldape K; Armstrong TS; Gilbert MR
    Neurooncol Adv; 2024; 6(1):vdad164. PubMed ID: 38292240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic glioblastoma to the lungs: a case report and literature review.
    Yuen CA; Pekmezci M; Bao S; Kong XT
    CNS Oncol; 2024 Jun; 13(1):2351789. PubMed ID: 38864820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma? An Update of the Clinical, Radiological, and Biomolecular Characteristics.
    La Torre D; Della Torre A; Lo Turco E; Longo P; Pugliese D; Lacroce P; Raudino G; Romano A; Lavano A; Tomasello F
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile.
    Sato Y; Deguchi S; Norose T; Oishi T; Mitsuya K; Sugino T; Akiyama Y; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Hayashi N; Yamaguchi K
    Nagoya J Med Sci; 2023 Nov; 85(4):828-835. PubMed ID: 38155632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care.
    Tu SM; Chen JZ; Singh SR; Aydin AM; Gokden N; Tam NNC; Leung YK; Langford T; Ho SM
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations.
    Zhang J; Croft J; Le A
    J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.
    Cheng CD; Chen C; Wang L; Dong YF; Yang Y; Chen YN; Niu WX; Wang WC; Liu QS; Niu CS
    Anal Cell Pathol (Amst); 2022; 2022():2376288. PubMed ID: 35757013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients.
    Kavouridis VK; Ligon KL; Wen PY; Iorgulescu JB
    J Neurooncol; 2022 May; 158(1):111-116. PubMed ID: 35474499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Correlation and Role of Cyclin D1 Expression in Glioblastoma Patients: A Study From North India.
    Jaiswal M; Tripathi A; Singh D; Kumar A; Singh M; Batra N; Verma A
    Cureus; 2022 Feb; 14(2):e22346. PubMed ID: 35223330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alteration and clonal evolution of primary glioblastoma into secondary gliosarcoma.
    Li J; Zhao YH; Tian SF; Xu CS; Cai YX; Li K; Cheng YB; Wang ZF; Li ZQ
    CNS Neurosci Ther; 2021 Dec; 27(12):1483-1492. PubMed ID: 34605602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
    Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
    Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Olympios N; Gilard V; Marguet F; Clatot F; Di Fiore F; Fontanilles M
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33800183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.
    Din NU; Ishtiaq H; Rahim S; Abdul-Ghafar J; Ahmad Z
    BMC Pediatr; 2021 Feb; 21(1):101. PubMed ID: 33637068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermutated phenotype in gliosarcoma of the spinal cord.
    Hong CS; Kuzmik GA; Kundishora AJ; Elsamadicy AA; Koo AB; McGuone D; Blondin NA; DiLuna ML; Erson-Omay EZ
    NPJ Precis Oncol; 2021 Feb; 5(1):8. PubMed ID: 33580181
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.